These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5890823)

  • 21. Desmoid tumor in the abdominal wall after treatment with high dose estradiol for prostatic cancer.
    Svanvik J; Knutsson F; Jansson R; Ekman H
    Acta Chir Scand; 1982; 148(3):301-3. PubMed ID: 7136435
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of prostatic carcinoma with local injection of dithizone].
    Ishibe T; Fukushige M; Tanaka H; Mizoguchi M; Fujimoto Y
    Hinyokika Kiyo; 1968 Dec; 14(12):886-95. PubMed ID: 4180160
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of cancer of the prostate with depot estrogens].
    SALSANO D; ALPI M
    Minerva Med; 1958 Jun; 49(47):2367-70. PubMed ID: 13565669
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?
    Karlsson CT; Malmer B; Wiklund F; Grönberg H
    J Urol; 2006 Aug; 176(2):538-43. PubMed ID: 16813884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
    Marks TA; Petrow V
    Cancer Res; 1983 Aug; 43(8):3687-90. PubMed ID: 6861138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mesenteric venous thrombosis--a complication of estrogen therapy of prostatic cancer].
    Järhult J; Mårtensson O
    Lakartidningen; 1980 Aug; 77(35):2911-2. PubMed ID: 7453314
    [No Abstract]   [Full Text] [Related]  

  • 27. [The comparative efficacy of radiation and thermoradiation treatments in prostatic cancer].
    Tkachev SI; Bukharkin BV; Sholokhov VN; Klimakov BD
    Urol Nefrol (Mosk); 1996; (1):25-8. PubMed ID: 8659038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy: is it effective in treatment of prostatic cancer?
    Murphy GP
    Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer of the prostate: metabolic effects of percutaneously administered beta-estradiol].
    Steg A; Benoit G; Limouzin-Lamotte A; Mahoudeau J; Caillens M; Raichvarg D
    Rev Med Suisse Romande; 1980 Nov; 100(11):895-7. PubMed ID: 7466061
    [No Abstract]   [Full Text] [Related]  

  • 30. [LHRH analogs--new possibilities in the treatment of prostatic cancer].
    Baranowska B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1009-12. PubMed ID: 6239145
    [No Abstract]   [Full Text] [Related]  

  • 31. Estracyt in advanced prostatic carcinoma. Case report.
    Nilsson T; Müntzing J
    Scand J Urol Nephrol; 1972; 6(1):11-6. PubMed ID: 5057614
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormonal, radiation and combined therapy of locally advanced prostatic cancer (T3NXM0)].
    Pavlov AS; Loran OB; Simakina EP; Tomkevich BA; Repina AG; Gribova RG
    Urologiia; 2005; (4):24-6. PubMed ID: 16158741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin].
    Fujimoto Y; Okano M; Takeuchi T; Saito A; Fujihiro S; Kuriyama M; Sakai S; Nishiura T
    Hinyokika Kiyo; 1983 Nov; 29(11):1433-41. PubMed ID: 6203378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative treatment of prostate cancer.
    Barry HC
    J Fam Pract; 1996 Mar; 42(3):224, 226. PubMed ID: 8636669
    [No Abstract]   [Full Text] [Related]  

  • 35. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
    Garcia GE; Wisniewski HG; Lucia MS; Arevalo N; Slaga TJ; Kraft SL; Strange R; Kumar AP
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):980-8. PubMed ID: 16467113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostatic hormone-resistant cancer: present-day drug prophylaxis and treatment].
    Sivkov AV; Alfimov AE; Imamov OE
    Urologiia; 1999; (5):33-9. PubMed ID: 11150155
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hormonal treatment of advanced prostate cancer].
    Faris G; Stein A; Lurie A
    Harefuah; 1993 Jan; 124(1):35-40. PubMed ID: 8436310
    [No Abstract]   [Full Text] [Related]  

  • 38. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist].
    Labrie F; Dupont A; Belanger A; Lefebvre FA; Raynaud JP
    J Pharmacol; 1983; 14 Suppl 3():117-35. PubMed ID: 6423907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1993 Jan; 39(1):23-8. PubMed ID: 8460581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group.
    Akaza H; Usami M; Kotake T; Koiso K; Aso Y
    Jpn J Clin Oncol; 1993 Jun; 23(3):178-85. PubMed ID: 7688829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.